Are women at high risk for serous gynaecological cancer (SGC) opting for risk-reducing salphingo-oophorectomy motivated by high levels of anxiety and risk perceptions?

Are women at high risk for serous gynaecological cancer (SGC) opting for risk-reducing salphingo-oophorectomy motivated by high levels of anxiety and risk perceptions?

Bibliographic Details
Main Authors:	Meiser B, Price MA, Butow PN, Karatas J, Charles M, Phillips KA
Format:	Article
Language:	English
Published:	BMC 2012-04-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S2/A5

Similar Items

Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
by: P. I. Stanciu, et al.
Published: (2019-05-01)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
by: Michael G. Schrauder, et al.
Published: (2019-09-01)

Bone density loss after risk reducing salpingo-oophorectomy
by: Andrews L, et al.
Published: (2012-04-01)

High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy
by: Domenica Lorusso, et al.
Published: (2013-01-01)

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
by: Nora Johansen, MD, et al.
Published: (2018-06-01)

Gynaecological Cancers Risk Breast Cancer, Ovarian Cancer and Endometrial Cancer
Published: (2022)

Serous Tubal Intraepithelial Carcinoma: An Incidental Finding at the Time of Prophylactic Bilateral Salpingo-Oophorectomy
by: Monique Hiersoux Vaughan, et al.
Published: (2015-01-01)

Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy
by: Howard A Fuchsia, et al.
Published: (2010-08-01)

Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
by: Sun-young Park, et al.
Published: (2020-12-01)

Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The “Opt-Out” Process
by: Jacob McGee, et al.
Published: (2019-01-01)

“Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty”
by: Dominique R. Malacarne, et al.
Published: (2017-12-01)

Immunotherapy of Gynaecological High-Risk Human Papilloma Virus Infection With Human Leukocyte Ultrafiltrate
by: H. Spitzbart, et al.
Published: (2000-01-01)

Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers
by: Sumin Chae, et al.
Published: (2021-08-01)

The risk of developing atherosclerosis and osteoporosis in post-oophorectomy women during hormone replacement therapy
by: E Iu Maĭchuk, et al.
Published: (2014-08-01)

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer.
by: Ingrid E Fakkert, et al.
Published: (2017-01-01)

Remarks on oophorectomy
by: Lauder, William
Published: (1886)

Rehabilitating the sick role: post-surgical experiences of high risk women who undergo risk reducing mastectomy
by: Hallowell N, et al.
Published: (2012-04-01)

Effects of hormone replacement therapy on depressive and anxiety symptoms after oophorectomy
by: Danijela D. Ðoković, et al.
Published: (2015-02-01)

Anxiety experienced in high-risk pregnancy
by: Inga Janik, et al.
Published: (2018-08-01)

The prevalence and risk factors of sexual dysfunction in gynaecological cancer patients.
by: Tee, BC, et al.
Published: (2014)

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
by: Rosa Lauretta, et al.
Published: (2016-01-01)

Germline , variants in a patient with breast and ovarian cancer at risk for familial cancer syndrome: Is there a role for risk-reducing salpingo-oophorectomy?
by: Semiramis L. Carbajal-Mamani, et al.
Published: (2020-03-01)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
by: Nasim Mavaddat, et al.
Published: (2020-01-01)

Private Enforcement and Opt-out SystemRisks, Rewards and Legal Safeguards
by: Maria Elisabete Ramos
Published: (2018-12-01)

Hereditary gynaecologic cancers in Nepal: a proposed model of care to serve high risk populations in developing countries
by: Hanoon P. Pokharel, et al.
Published: (2017-09-01)

Prophylactic salpingo-oophorectomy & surgical menopause for inherited risks of cancer: the need to identify biomarkers to assess the theoretical risk of premature coronary artery disease
by: Zarah Batulan, et al.
Published: (2018-04-01)

Venous thromboembolism: Risk profile and management of prophylaxis in gynaecological surgery patients
by: Janine Potgieter, et al.
Published: (2014-11-01)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
by: Nasim Mavaddat, et al.
Published: (2020-02-01)

The Optimizing-Risk-Communication (OptRisk) randomized trial – impact of decision-aid-based consultation on adherence and perception of cardiovascular risk
by: Adarkwah CC, et al.
Published: (2019-03-01)

Feasibility of risk reducing salpingo-oophorectomy at the time of abdominal surgery for correction of pelvic organ prolapse and urinary incontinence
by: Ali Azadi, et al.
Published: (2021-01-01)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
by: Janusz Menkiszak, et al.
Published: (2019-03-01)

Single-port versus conventional multiport access prophylactic laparoscopic bilateral salpingo-oophorectomy in high-risk patients for ovarian cancer: a comparison of surgical outcomes
by: Angioni S, et al.
Published: (2015-06-01)

The effects of oophorectomy on mineral metabolism
by: Aitken, J. M.
Published: (1975)

Investigations into effects of bilateral oophorectomy
by: Webb, Martha Beatrice
Published: (1908)

sGC Stimulators and Activators
by: Heli Tolppanen, et al.
Published: (2019-01-01)

<i>BRCA</i> Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
by: Masayuki Sekine, et al.
Published: (2021-05-01)

Neural Correlates of Anticipation in Children at High Risk for Anxiety
by: Clauss, Jacqueline Alexandra
Published: (2014)

Assessment of anxiety and depression in patients with advanced gynaecological cancer
by: Roxana-Andreea Rahnea-Nita, et al.
Published: (2019-08-01)

Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy
by: Jia Yu, et al.
Published: (2019-01-01)

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?
by: Hallowell N, et al.
Published: (2012-04-01)